Submitted by Anonymous (not verified) on 10 November 2026 - 11:25
Human medicines European public assessment report (EPAR): Andembry, garadacimab, Date of authorisation: 10/02/2025, Revision: 3, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Andembry, garadacimab, Date of authorisation: 10/02/2025, Revision: 3, Status: Authorised